Dr. Yvonne Smyth:

Absolutely. There is an international trial called the paradigm study looking at heart failure patients throughout the world demonstrating the benefits of these agents.

We must remember heart failure is a terrible condition. It has outcomes worse than many cancers. It is a big cause of admissions to our acute hospitals. Typically, patients will stay an average of eight to ten days. Anything we can do to help these patients stay out of hospital has a tremendous impact.